Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:SBUX
NasdaqGS:SBUXHospitality

Starbucks (SBUX) Q1 2026 Margin Compression Reinforces Bearish Profitability Narratives

Starbucks (SBUX) opened fiscal Q1 2026 with revenue of US$9.9b and basic EPS of US$0.26, alongside net income of US$293.3m, setting the tone for how investors assess the latest quarter against a year of softer profitability. Over the past year, the company has seen quarterly revenue range from US$8.8b to US$9.6b and EPS move between US$0.12 and US$0.69, while trailing twelve month figures sit at US$37.7b of revenue, EPS of US$1.20 and net income of US$1.37b. With the trailing net margin at 5%...
NasdaqCM:JMSB
NasdaqCM:JMSBBanks

John Marshall Bancorp (JMSB) Net Interest Margin Rebound Tests Long Term Earnings Decline Narrative

John Marshall Bancorp (JMSB) just turned in another steady quarter for FY 2025, with Q3 revenue of about US$15.9 million and basic EPS of roughly US$0.38 on net income of US$5.4 million. The bank has seen revenue move from US$13.4 million and EPS of about US$0.30 in Q3 2024 to US$15.9 million and EPS of roughly US$0.38 in Q3 2025. Trailing 12 month EPS sits around US$1.41 on net income of about US$20.0 million, which highlights a story where higher earnings and firmer profitability metrics...
NYSE:AR
NYSE:AROil and Gas

Is It Time To Reassess Antero Resources (AR) After Flat Recent Share Performance?

Investors may be wondering whether Antero Resources at around US$34.46 is offering good value right now or whether most of the potential upside has already been reflected in the price. The stock has been fairly flat in the short term, with a 0.6% move over the last week, a 0.4% decline over the last month, and a modest 0.7% return year to date. Over the last year the return sits at a 7.7% decline and the 3-year return at 23.4%. Over a 5-year period the share price change has been very large...
NasdaqGS:TSHA
NasdaqGS:TSHABiotechs

Why Taysha Gene Therapies (TSHA) Is Down 6.3% After Rett Trial Progress And Insider Stock Sales - And What's Next

Taysha Gene Therapies recently reported progress in its TSHA-102 gene therapy program for Rett syndrome, including dosing the first patient in the pivotal REVEAL trial and securing FDA alignment on the study design, while senior executives disclosed significant insider stock sales. This combination of clinical and regulatory milestones with insider activity offers a rare window into both the program’s momentum and leadership’s capital decisions. We’ll now examine how the FDA’s alignment on...
NYSE:NVR
NYSE:NVRConsumer Durables

NVR (NVR) Margin Compression To 13.5% Challenges Long Term Earnings Growth Narrative

NVR (NVR) has just posted its FY 2025 third quarter numbers, with revenue of US$2.6b and basic EPS of US$119.26, set against a trailing 12 month EPS of US$484.98 and revenue of US$10.6b. Over recent quarters, revenue has moved from US$2.6b in Q2 2025 and US$2.4b in Q1 2025, alongside basic EPS of US$114.52 and US$100.41 respectively. This gives investors a clear read on the run rate as they weigh the latest figures against a net profit margin that has eased from 15.9% to 13.5% over the past...
NasdaqCM:ORRF
NasdaqCM:ORRFBanks

Orrstown Financial Services (ORRF) Net Margin Surge Reinforces Bullish Profitability Narratives

Orrstown Financial Services (ORRF) has rounded out FY 2025 with fourth quarter revenue of US$64.8 million and basic EPS of US$1.12, alongside trailing twelve month revenue of US$252.1 million and EPS of US$4.21. Over the last few quarters, revenue has moved from US$60.1 million in Q4 2024 to US$64.8 million in Q4 2025, while quarterly basic EPS has shifted from US$0.72 to US$1.12 over the same period. This frames a year in which trailing net income reached US$80.9 million. With a trailing net...
TSX:CG
TSX:CGMetals and Mining

Centerra Gold (TSX:CG) Valuation After Mount Milligan Expansion Approvals And Positive Kemess PEA

Centerra Gold (TSX:CG) is back in focus after securing extended permits and a 10% planned throughput increase at its Mount Milligan mine, along with updated resource figures and a new preliminary economic assessment (PEA) for the Kemess project in British Columbia. See our latest analysis for Centerra Gold. Those permitting wins and the Kemess PEA land against a backdrop of strong recent momentum, with a 30 day share price return of 37.95% and a 1 year total shareholder return above 200%,...
NasdaqGS:GABC
NasdaqGS:GABCBanks

German American Bancorp (GABC) Net Interest Margin Improvement Tests Bullish Narratives

German American Bancorp (GABC) just posted its FY 2025 fourth quarter numbers, reporting revenue of US$94.0 million and EPS of US$0.95, supported by quarterly net income of US$35.7 million. The bank’s revenue moved from US$64.5 million in Q4 2024 to US$94.0 million in Q4 2025, while quarterly EPS increased from US$0.78 to US$0.95 over the same period, indicating a notably different earnings profile than a year ago. With a trailing 12 month net profit margin of 32% and a P/E above sector...
NasdaqGS:MAR
NasdaqGS:MARHospitality

Marriott’s Record 2025 Expansion And citizenM Deal Reshape Growth Story

Marriott International (NasdaqGS:MAR) reports record-breaking global expansion in 2025, adding over 700 properties and nearly 100,000 rooms worldwide. The company agrees to acquire lifestyle hotel group citizenM, expanding its footprint in the premium, design focused segment. Marriott announces new global development milestones and launches several new brands, including fresh concepts in luxury. For anyone following global lodging, Marriott International sits at the center of the branded...
NYSE:EAT
NYSE:EATHospitality

Brinker International (EAT) Margin Gains Challenge Cautious Narratives In Q2 2026 Results

Brinker International (EAT) just posted Q2 2026 results with revenue of US$1.35 billion and basic EPS of US$2.23, alongside net income of US$99.5 million, setting the tone for how its restaurant footprint and sales trends are feeding into profitability. The company has seen quarterly revenue move from US$1.36 billion in Q2 2025 to US$1.43 billion in Q3 2025 and US$1.46 billion in Q4 2025, while basic EPS over that stretch ran from US$2.67 in Q2 2025 to US$2.68 in Q3 2025 and US$2.40 in Q4...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

Teva Pharmaceutical Industries (NYSE:TEVA) Earnings Margin Recovery Challenges High P/E Valuation Narrative

Teva Pharmaceutical Industries (NYSE:TEVA) has just posted its FY 2025 third quarter numbers, with revenue of US$4.5b and basic EPS of US$0.38, as the trailing 12 month line shows revenue of US$16.8b and basic EPS of US$0.62. Over recent quarters the company has seen revenue range from US$4.2b in Q4 2024 to US$4.5b in Q3 2025, while basic EPS moved from a loss of US$0.19 in Q4 2024 to a profit of US$0.38 in Q3 2025. This sets up a story where margin trends and the mix of products in late...
NasdaqGS:HAFC
NasdaqGS:HAFCBanks

Hanmi Financial (HAFC) Net Interest Margin Strength Reinforces Bullish Valuation Narratives

Hanmi Financial’s latest numbers set the stage Hanmi Financial (HAFC) has just wrapped up FY 2025 with Q4 revenue of US$69.2 million and EPS of US$0.73, capping a trailing twelve month run that totals US$255.7 million in revenue and EPS of US$2.55. Over the past few quarters, revenue has moved from US$56.2 million in Q3 2024 to US$59.9 million in Q4 2024, then to US$60.1 million in Q1 2025 and US$57.6 million in Q2 2025 before reaching US$68.8 million in Q3 and US$69.2 million in Q4, while...
NasdaqCM:CBK
NasdaqCM:CBKBanks

Commercial Bancgroup (CBK) Cost Efficiency Gains Challenge Cautious Earnings Narratives

Commercial Bancgroup (CBK) has just posted its FY 2025 numbers, with fourth quarter revenue of US$23.3 million and basic EPS of US$0.72, set against trailing twelve month revenue of US$90.2 million and EPS of US$2.93 that reflect 6% revenue growth and a net profit margin of 36.4% versus 36.9% a year earlier. Over the past two reported fourth quarters, revenue moved from US$78.4 million on a trailing basis to US$90.2 million, while trailing EPS went from US$2.52 to US$2.93. This gives...
NYSE:OMC
NYSE:OMCMedia

Does Slowing Organic Growth And Weaker Cash Returns Change The Bull Case For Omnicom Group (OMC)?

Recent commentary on Omnicom Group highlights that the company’s organic revenue growth has slowed to an average 4.3% year-on-year over the last two years, alongside a substantial drop in free cash flow margin and return on invested capital. These trends point to rising capital intensity and fewer high-return opportunities, prompting investors to reassess the quality and sustainability of Omnicom’s underlying cash generation. Given the recent share price declines, we’ll examine how waning...